

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.60584083 |
| 2 | response to peptidoglycan (GO:0032494) | 5.38587438 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.68781928 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.27480542 |
| 5 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.21779096 |
| 6 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.05805409 |
| 7 | response to muramyl dipeptide (GO:0032495) | 3.81531626 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.59672690 |
| 9 | neutrophil activation (GO:0042119) | 3.55347080 |
| 10 | granulocyte activation (GO:0036230) | 3.54798153 |
| 11 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40270798 |
| 12 | regulation of integrin activation (GO:0033623) | 3.36800193 |
| 13 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.35134512 |
| 14 | negative regulation of interleukin-8 production (GO:0032717) | 3.33089937 |
| 15 | natural killer cell activation involved in immune response (GO:0002323) | 3.29916724 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29081215 |
| 17 | regulation of vitamin metabolic process (GO:0030656) | 3.27789381 |
| 18 | cellular response to arsenic-containing substance (GO:0071243) | 3.25367197 |
| 19 | Rap protein signal transduction (GO:0032486) | 3.21609437 |
| 20 | cellular extravasation (GO:0045123) | 3.08210726 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 2.93353275 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 2.91460345 |
| 23 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91339167 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.90876997 |
| 25 | megakaryocyte development (GO:0035855) | 2.88790875 |
| 26 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.88551632 |
| 27 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.86996593 |
| 28 | thrombin receptor signaling pathway (GO:0070493) | 2.86055770 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85932123 |
| 30 | histamine secretion (GO:0001821) | 2.84033072 |
| 31 | positive regulation of macrophage differentiation (GO:0045651) | 2.79517776 |
| 32 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.77282484 |
| 33 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.77282484 |
| 34 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76891521 |
| 35 | germinal center formation (GO:0002467) | 2.76383051 |
| 36 | cell wall macromolecule catabolic process (GO:0016998) | 2.75307706 |
| 37 | positive regulation of extracellular matrix organization (GO:1903055) | 2.70039187 |
| 38 | pinocytosis (GO:0006907) | 2.69712691 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 2.66660118 |
| 40 | platelet aggregation (GO:0070527) | 2.65866632 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 2.65298934 |
| 42 | regulation of platelet activation (GO:0010543) | 2.64141893 |
| 43 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.64132323 |
| 44 | response to laminar fluid shear stress (GO:0034616) | 2.63299321 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.61249102 |
| 46 | regulation of mast cell activation (GO:0033003) | 2.59242510 |
| 47 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.58664886 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57452204 |
| 49 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.56993367 |
| 50 | regulation of interferon-alpha production (GO:0032647) | 2.56746217 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 2.56174625 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 2.51465806 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50742242 |
| 54 | regulation of chronic inflammatory response (GO:0002676) | 2.49939055 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 2.49521389 |
| 56 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.49445744 |
| 57 | regulation of growth of symbiont in host (GO:0044126) | 2.49445744 |
| 58 | negative regulation of growth of symbiont in host (GO:0044130) | 2.49445744 |
| 59 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.49445744 |
| 60 | leukocyte degranulation (GO:0043299) | 2.49037070 |
| 61 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.47554762 |
| 62 | positive regulation of interleukin-6 production (GO:0032755) | 2.46983197 |
| 63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46596457 |
| 64 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.44966015 |
| 65 | glycosphingolipid catabolic process (GO:0046479) | 2.44213589 |
| 66 | neutrophil mediated immunity (GO:0002446) | 2.42597004 |
| 67 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.42444347 |
| 68 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.41659298 |
| 69 | embryonic process involved in female pregnancy (GO:0060136) | 2.41531151 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.41452074 |
| 71 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.39766779 |
| 72 | regulation of interleukin-12 production (GO:0032655) | 2.39628600 |
| 73 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.39549421 |
| 74 | negative regulation of interleukin-6 production (GO:0032715) | 2.38714191 |
| 75 | regulation of interleukin-6 production (GO:0032675) | 2.37979537 |
| 76 | macrophage activation (GO:0042116) | 2.37836393 |
| 77 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.37316253 |
| 78 | NIK/NF-kappaB signaling (GO:0038061) | 2.36986739 |
| 79 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.36961549 |
| 80 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.36090231 |
| 81 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.35842993 |
| 82 | establishment of endothelial barrier (GO:0061028) | 2.35279523 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.34960705 |
| 84 | definitive hemopoiesis (GO:0060216) | 2.34823445 |
| 85 | cellular response to lipopolysaccharide (GO:0071222) | 2.34266853 |
| 86 | neutrophil chemotaxis (GO:0030593) | 2.33437570 |
| 87 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.33111021 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 2.33085681 |
| 89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.33085681 |
| 90 | regulation of platelet aggregation (GO:0090330) | 2.33057121 |
| 91 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.32760405 |
| 92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.32760405 |
| 93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.32760405 |
| 94 | modulation by symbiont of host immune response (GO:0052553) | 2.32760405 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 2.32760405 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 2.32760405 |
| 97 | necroptotic process (GO:0070266) | 2.31894756 |
| 98 | positive regulation of interferon-beta production (GO:0032728) | 2.31346556 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 2.30932321 |
| 100 | stress fiber assembly (GO:0043149) | 2.30765777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.78058198 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.98500017 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.74072623 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.32203791 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.31561612 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27900035 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16628111 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11576917 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.11076444 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06593638 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.03818290 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80072321 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.74750785 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.65639084 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.59793170 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42735516 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.29388021 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26828062 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19531824 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.16072332 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.11826821 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01819729 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01402959 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99824507 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.99229707 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91605352 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.84673665 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82713723 |
| 29 | GATA1_19941826_ChIP-Seq_K562_Human | 1.77227450 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74452671 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68361126 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68146372 |
| 33 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.65159893 |
| 34 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.65159893 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65066135 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64360754 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64168227 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63741473 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62960275 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61353979 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.59790152 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.58588905 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56605738 |
| 44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.56348656 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55935543 |
| 46 | GATA2_19941826_ChIP-Seq_K562_Human | 1.54695836 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50908778 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.49012707 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47542763 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46528070 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46062832 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40933865 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40455974 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37972992 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36182857 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35365183 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.35054791 |
| 58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35023384 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32376831 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32352819 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30936680 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30031084 |
| 63 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28126222 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.28022287 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23541592 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22383902 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21505726 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20516794 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18604748 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17132199 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16805031 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14436416 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14045467 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13943448 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13620984 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13546395 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12782019 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11912476 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11360239 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11051898 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10670377 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10350896 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10285422 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10116339 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09441740 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09319239 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09119275 |
| 88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07940319 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05446333 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03207851 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03076755 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02566374 |
| 93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02111709 |
| 94 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00858156 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99985949 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99635773 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97305413 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88558984 |
| 99 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.87734699 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86674759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.35312502 |
| 2 | MP0005464_abnormal_platelet_physiology | 3.27520048 |
| 3 | MP0003436_decreased_susceptibility_to | 2.92375438 |
| 4 | MP0003724_increased_susceptibility_to | 2.79537099 |
| 5 | MP0003828_pulmonary_edema | 2.79131122 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.61614826 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.60531240 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.31238562 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.31085292 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.29012847 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.27361966 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.26682857 |
| 13 | MP0004947_skin_inflammation | 2.21613737 |
| 14 | MP0002419_abnormal_innate_immunity | 2.14367475 |
| 15 | MP0001853_heart_inflammation | 2.12214974 |
| 16 | MP0008004_abnormal_stomach_pH | 2.09466565 |
| 17 | MP0009840_abnormal_foam_cell | 2.03867609 |
| 18 | MP0009785_altered_susceptibility_to | 1.96780813 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.93007869 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.93007869 |
| 21 | MP0004510_myositis | 1.90954213 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.86855253 |
| 23 | MP0009278_abnormal_bone_marrow | 1.86435099 |
| 24 | MP0006082_CNS_inflammation | 1.85641781 |
| 25 | MP0005025_abnormal_response_to | 1.82347035 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.82197938 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.79405921 |
| 28 | MP0001800_abnormal_humoral_immune | 1.74488473 |
| 29 | MP0002723_abnormal_immune_serum | 1.71428901 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.68285223 |
| 31 | MP0009764_decreased_sensitivity_to | 1.65622831 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.61988842 |
| 33 | MP0006054_spinal_hemorrhage | 1.59727731 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.58956276 |
| 35 | MP0008057_abnormal_DNA_replication | 1.55786088 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.55401618 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.55131815 |
| 38 | MP0003448_altered_tumor_morphology | 1.54558371 |
| 39 | MP0001819_abnormal_immune_cell | 1.54380921 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.54084008 |
| 41 | MP0002009_preneoplasia | 1.46255364 |
| 42 | MP0000343_altered_response_to | 1.44942548 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.44174078 |
| 44 | MP0001851_eye_inflammation | 1.43972126 |
| 45 | MP0002398_abnormal_bone_marrow | 1.41926280 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.36931752 |
| 47 | MP0000685_abnormal_immune_system | 1.35970321 |
| 48 | MP0003091_abnormal_cell_migration | 1.35014209 |
| 49 | MP0001790_abnormal_immune_system | 1.33550558 |
| 50 | MP0005387_immune_system_phenotype | 1.33550558 |
| 51 | MP0002405_respiratory_system_inflammati | 1.32365007 |
| 52 | MP0003453_abnormal_keratinocyte_physiol | 1.28364707 |
| 53 | MP0005671_abnormal_response_to | 1.25892480 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.23810555 |
| 55 | MP0003075_altered_response_to | 1.23273187 |
| 56 | MP0005451_abnormal_body_composition | 1.22883293 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.22351384 |
| 58 | MP0000716_abnormal_immune_system | 1.22111655 |
| 59 | MP0005310_abnormal_salivary_gland | 1.21416657 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.18717466 |
| 61 | MP0005647_abnormal_sex_gland | 1.18412181 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.18176514 |
| 63 | MP0000858_altered_metastatic_potential | 1.15811518 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.15284794 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.13839017 |
| 66 | MP0005164_abnormal_response_to | 1.11605389 |
| 67 | MP0002429_abnormal_blood_cell | 1.10835157 |
| 68 | MP0002722_abnormal_immune_system | 1.10627092 |
| 69 | MP0008260_abnormal_autophagy | 1.09229657 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 1.09213093 |
| 71 | MP0008469_abnormal_protein_level | 1.08953813 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.08239236 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.06137589 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.04440409 |
| 75 | MP0003763_abnormal_thymus_physiology | 1.03943345 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.03371812 |
| 77 | MP0002006_tumorigenesis | 1.02180764 |
| 78 | MP0009763_increased_sensitivity_to | 1.00459112 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.99564770 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.99452969 |
| 81 | MP0004883_abnormal_blood_vessel | 0.95803542 |
| 82 | MP0002254_reproductive_system_inflammat | 0.95331681 |
| 83 | MP0005166_decreased_susceptibility_to | 0.94566186 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91534886 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.84786549 |
| 86 | MP0005670_abnormal_white_adipose | 0.84624174 |
| 87 | MP0000249_abnormal_blood_vessel | 0.84151502 |
| 88 | MP0001216_abnormal_epidermal_layer | 0.81767805 |
| 89 | MP0005390_skeleton_phenotype | 0.81397089 |
| 90 | MP0005023_abnormal_wound_healing | 0.80176069 |
| 91 | MP0005621_abnormal_cell_physiology | 0.79987915 |
| 92 | MP0005165_increased_susceptibility_to | 0.79847182 |
| 93 | MP0002132_abnormal_respiratory_system | 0.79831586 |
| 94 | MP0010307_abnormal_tumor_latency | 0.79706371 |
| 95 | MP0003045_fibrosis | 0.78946379 |
| 96 | MP0003795_abnormal_bone_structure | 0.74158631 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.73923408 |
| 98 | MP0001663_abnormal_digestive_system | 0.73729124 |
| 99 | MP0005083_abnormal_biliary_tract | 0.73701229 |
| 100 | MP0001191_abnormal_skin_condition | 0.73522936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 4.98826720 |
| 2 | Petechiae (HP:0000967) | 4.74480871 |
| 3 | Abnormal platelet volume (HP:0011876) | 4.19586860 |
| 4 | Increased mean platelet volume (HP:0011877) | 4.19571443 |
| 5 | Stomatitis (HP:0010280) | 4.03457251 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92501421 |
| 7 | Menorrhagia (HP:0000132) | 3.77285994 |
| 8 | Epistaxis (HP:0000421) | 3.70343778 |
| 9 | Purpura (HP:0000979) | 3.66641915 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.48128127 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.35324404 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.31110463 |
| 13 | Autoimmune hemolytic anemia (HP:0001890) | 3.12831133 |
| 14 | Gingival bleeding (HP:0000225) | 3.12706931 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.08567373 |
| 16 | Impaired platelet aggregation (HP:0003540) | 3.06267392 |
| 17 | Abnormal platelet function (HP:0011869) | 3.06267392 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99926414 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99926414 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99926414 |
| 21 | Recurrent viral infections (HP:0004429) | 2.99632813 |
| 22 | Amyloidosis (HP:0011034) | 2.98961271 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 2.98850885 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.95154264 |
| 25 | Spondylolisthesis (HP:0003302) | 2.86695649 |
| 26 | Optic neuritis (HP:0100653) | 2.72647483 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.72647483 |
| 28 | Hematochezia (HP:0002573) | 2.65359674 |
| 29 | Myositis (HP:0100614) | 2.64266004 |
| 30 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.62113202 |
| 31 | Orchitis (HP:0100796) | 2.61901565 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61242536 |
| 33 | Abnormality of the prostate (HP:0008775) | 2.59711502 |
| 34 | Myocardial infarction (HP:0001658) | 2.57742038 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.55334325 |
| 36 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.51067646 |
| 37 | Hepatosplenomegaly (HP:0001433) | 2.47986890 |
| 38 | Loss of speech (HP:0002371) | 2.46609095 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44308950 |
| 40 | Increased serum ferritin (HP:0003281) | 2.36403763 |
| 41 | Viral hepatitis (HP:0006562) | 2.35444250 |
| 42 | Episodic fever (HP:0001954) | 2.33715476 |
| 43 | Acute myeloid leukemia (HP:0004808) | 2.32111365 |
| 44 | Conjunctival telangiectasia (HP:0000524) | 2.31334394 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.29817925 |
| 46 | Arterial thrombosis (HP:0004420) | 2.27766128 |
| 47 | Polycythemia (HP:0001901) | 2.24999334 |
| 48 | Encephalitis (HP:0002383) | 2.24316537 |
| 49 | Vasculitis (HP:0002633) | 2.24216689 |
| 50 | Prostate neoplasm (HP:0100787) | 2.22627043 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.22303939 |
| 52 | Recurrent skin infections (HP:0001581) | 2.21863954 |
| 53 | Tetraparesis (HP:0002273) | 2.20677787 |
| 54 | Increased IgM level (HP:0003496) | 2.20457212 |
| 55 | Granulocytopenia (HP:0001913) | 2.19902024 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.18943379 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.16767310 |
| 58 | Axonal loss (HP:0003447) | 2.14965927 |
| 59 | Leukocytosis (HP:0001974) | 2.13244939 |
| 60 | Stomach cancer (HP:0012126) | 2.13091965 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.13055943 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11862950 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11862950 |
| 64 | Slow saccadic eye movements (HP:0000514) | 2.09734948 |
| 65 | Fatigue (HP:0012378) | 2.09618521 |
| 66 | Follicular hyperkeratosis (HP:0007502) | 2.07969024 |
| 67 | Poikilocytosis (HP:0004447) | 2.06970766 |
| 68 | Keratoconjunctivitis (HP:0001096) | 2.02913957 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02008933 |
| 70 | Obstructive lung disease (HP:0006536) | 2.02008933 |
| 71 | Paralysis (HP:0003470) | 1.97062629 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96799846 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96799846 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96799846 |
| 75 | Eosinophilia (HP:0001880) | 1.94844432 |
| 76 | Pulmonary infiltrates (HP:0002113) | 1.93798077 |
| 77 | Alopecia of scalp (HP:0002293) | 1.93286068 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 1.92790996 |
| 79 | Abnormality of B cell number (HP:0010975) | 1.92148791 |
| 80 | Abnormality of lateral ventricle (HP:0030047) | 1.92129926 |
| 81 | Erythema (HP:0010783) | 1.91258283 |
| 82 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90486226 |
| 83 | Relative macrocephaly (HP:0004482) | 1.89691895 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89329526 |
| 85 | Mucopolysacchariduria (HP:0008155) | 1.89329526 |
| 86 | Acanthocytosis (HP:0001927) | 1.89323477 |
| 87 | Subacute progressive viral hepatitis (HP:0006572) | 1.89141456 |
| 88 | Nausea (HP:0002018) | 1.88829554 |
| 89 | Alveolar cell carcinoma (HP:0006519) | 1.88312284 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 1.87872908 |
| 91 | Lower limb hyperreflexia (HP:0002395) | 1.84748598 |
| 92 | Anhidrosis (HP:0000970) | 1.84204915 |
| 93 | Dyschromatopsia (HP:0007641) | 1.83863463 |
| 94 | B lymphocytopenia (HP:0010976) | 1.82645781 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79770863 |
| 96 | Abnormality of the common coagulation pathway (HP:0010990) | 1.79298149 |
| 97 | Ocular albinism (HP:0001107) | 1.77799728 |
| 98 | Bruising susceptibility (HP:0000978) | 1.77013990 |
| 99 | Osteomyelitis (HP:0002754) | 1.76813278 |
| 100 | Distal lower limb amyotrophy (HP:0008944) | 1.76753950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.60121775 |
| 2 | BMPR2 | 3.49668655 |
| 3 | MAP3K14 | 3.30315653 |
| 4 | MST4 | 3.30140604 |
| 5 | PRPF4B | 3.29287325 |
| 6 | RIPK4 | 3.05927939 |
| 7 | MAP3K3 | 2.64923821 |
| 8 | TEC | 2.62656284 |
| 9 | SIK3 | 2.51462778 |
| 10 | MAP2K3 | 2.40688562 |
| 11 | TAOK2 | 2.25705414 |
| 12 | IKBKB | 2.22112558 |
| 13 | BTK | 2.02932961 |
| 14 | GRK7 | 1.89775576 |
| 15 | IRAK4 | 1.88736552 |
| 16 | MATK | 1.84687512 |
| 17 | IRAK1 | 1.82787852 |
| 18 | IRAK2 | 1.82019777 |
| 19 | EIF2AK3 | 1.75829608 |
| 20 | ZAP70 | 1.70651061 |
| 21 | TBK1 | 1.67052713 |
| 22 | EIF2AK1 | 1.61793345 |
| 23 | TYK2 | 1.50774523 |
| 24 | BRSK2 | 1.47653781 |
| 25 | IKBKE | 1.41073461 |
| 26 | AKT3 | 1.33144455 |
| 27 | PIK3CG | 1.31399173 |
| 28 | DYRK3 | 1.28901874 |
| 29 | TAOK1 | 1.28159505 |
| 30 | BLK | 1.26612021 |
| 31 | STK24 | 1.25153512 |
| 32 | STK10 | 1.17562742 |
| 33 | ITK | 1.16199118 |
| 34 | SYK | 1.13784284 |
| 35 | CDK12 | 1.11891135 |
| 36 | HCK | 1.10748645 |
| 37 | MOS | 1.07420914 |
| 38 | CHUK | 1.05521887 |
| 39 | STK3 | 1.04982074 |
| 40 | FGR | 1.01887239 |
| 41 | TRPM7 | 1.01027958 |
| 42 | BMX | 1.00783505 |
| 43 | MARK3 | 0.97897914 |
| 44 | TNK2 | 0.96105096 |
| 45 | NME2 | 0.93265408 |
| 46 | TGFBR2 | 0.91486531 |
| 47 | EPHA2 | 0.91173543 |
| 48 | JAK3 | 0.90552183 |
| 49 | MAP3K5 | 0.89870375 |
| 50 | TAOK3 | 0.89160834 |
| 51 | GRK6 | 0.88075150 |
| 52 | CSK | 0.85444965 |
| 53 | JAK1 | 0.85083705 |
| 54 | WEE1 | 0.84221291 |
| 55 | MAP3K1 | 0.83653945 |
| 56 | MAP4K1 | 0.79577877 |
| 57 | KIT | 0.78602610 |
| 58 | CLK1 | 0.78103783 |
| 59 | FES | 0.76287490 |
| 60 | MKNK2 | 0.74028344 |
| 61 | MAPK7 | 0.69451806 |
| 62 | CDK6 | 0.67937553 |
| 63 | LYN | 0.67629662 |
| 64 | TXK | 0.67575806 |
| 65 | ERBB3 | 0.64532576 |
| 66 | YES1 | 0.61980497 |
| 67 | SGK3 | 0.61254602 |
| 68 | STK38L | 0.60899413 |
| 69 | JAK2 | 0.59785344 |
| 70 | GSK3A | 0.59358235 |
| 71 | NEK9 | 0.56556428 |
| 72 | CSF1R | 0.55601535 |
| 73 | MYLK | 0.55210303 |
| 74 | NEK6 | 0.53840061 |
| 75 | RPS6KA4 | 0.50328043 |
| 76 | PIM2 | 0.49096966 |
| 77 | CDC42BPA | 0.48382308 |
| 78 | MAP3K11 | 0.44970828 |
| 79 | MAP3K13 | 0.43889490 |
| 80 | EIF2AK2 | 0.43033161 |
| 81 | PDK2 | 0.41998797 |
| 82 | PAK4 | 0.40917891 |
| 83 | TRIM28 | 0.40707398 |
| 84 | PAK1 | 0.40475361 |
| 85 | MAP3K8 | 0.39107392 |
| 86 | ABL1 | 0.38860528 |
| 87 | BRD4 | 0.38293091 |
| 88 | LCK | 0.38272917 |
| 89 | PDK1 | 0.38192034 |
| 90 | MKNK1 | 0.37567054 |
| 91 | MTOR | 0.35980512 |
| 92 | MAP2K1 | 0.35699107 |
| 93 | PTK2B | 0.35560249 |
| 94 | ERN1 | 0.35098000 |
| 95 | DDR2 | 0.35055962 |
| 96 | TTN | 0.34751224 |
| 97 | BCR | 0.32988295 |
| 98 | LATS2 | 0.31772963 |
| 99 | SGK2 | 0.31642721 |
| 100 | ABL2 | 0.31468578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39012387 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30772642 |
| 3 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.24389126 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23940942 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.16570817 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.15706480 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11022609 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02538959 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01358628 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96299646 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92468989 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.84840663 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.75035718 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 1.68437087 |
| 15 | Hepatitis B_Homo sapiens_hsa05161 | 1.63351512 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.62188302 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59051069 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.57929345 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56804737 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.53860213 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52911878 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.50883384 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47890054 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47283733 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44882363 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41894516 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37048017 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35065168 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.32411015 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29695848 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27761847 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27446665 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.27342046 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24502388 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23510363 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19900309 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.19009693 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18517115 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.18117114 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.16560080 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14606606 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13523479 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.13007173 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11853629 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 1.10255232 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.08940048 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08754320 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.07814929 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07808465 |
| 50 | Prostate cancer_Homo sapiens_hsa05215 | 1.04519529 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02210391 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01942876 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00511229 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99413827 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97879926 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97565744 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.91956560 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91702304 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89441161 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87845748 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86021262 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84326932 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83786765 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83480367 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78356980 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77383632 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76756289 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76200241 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74775609 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74271476 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72372202 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70878800 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.68673178 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68613247 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.68549027 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68267251 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68169913 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68122595 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67813921 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65040481 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61962861 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61720929 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60769028 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59570198 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57607850 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57420994 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57054574 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55733791 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54485411 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52155234 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50156419 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49007141 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48123376 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47134151 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43712519 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.43439846 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42431630 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41764679 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41621366 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41232472 |

